From B-type natriuretic peptide to green mambas: the process of discovery
- PMID: 18582637
- DOI: 10.1016/j.jacc.2008.02.078
From B-type natriuretic peptide to green mambas: the process of discovery
Comment on
-
Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.J Am Coll Cardiol. 2008 Jul 1;52(1):60-8. doi: 10.1016/j.jacc.2008.02.077. J Am Coll Cardiol. 2008. PMID: 18582636 Free PMC article.
Similar articles
-
Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.J Am Coll Cardiol. 2008 Jul 1;52(1):60-8. doi: 10.1016/j.jacc.2008.02.077. J Am Coll Cardiol. 2008. PMID: 18582636 Free PMC article.
-
CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease.Curr Heart Fail Rep. 2010 Sep;7(3):93-9. doi: 10.1007/s11897-010-0016-6. Curr Heart Fail Rep. 2010. PMID: 20582736 Review.
-
Nesiritide: the latest drug for treating heart failure.Crit Care Nurse. 2006 Feb;26(1):39-44, 46-7. Crit Care Nurse. 2006. PMID: 16443809 Review. No abstract available.
-
The rise and fall of natriuretic peptides in acute kidney injury: a misunderstood relationship?Rev Cardiovasc Med. 2007;8 Suppl 5:S32-7. Rev Cardiovasc Med. 2007. PMID: 18192953 Review.
-
The clinical challenge of cardiorenal syndrome.Circulation. 2004 Sep 21;110(12):1514-7. doi: 10.1161/01.CIR.0000143547.55093.17. Circulation. 2004. PMID: 15381655 No abstract available.
Cited by
-
Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):98-105. doi: 10.1093/ehjcvp/pvv040. Epub 2015 Dec 10. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27340557 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources